Last updated on December 2013

A Study to Evaluate the Efficacy, Safety and Tolerability of Combinations Study medication and Mirabegron Compared to Study medication and Mirabegron Monotherapy in the Treatment of Overactive Bladder


Brief description of study

A Study to Evaluate the Efficacy, Safety and Tolerability of Combinations Study medication and Mirabegron Compared to Study medication and Mirabegron Monotherapy in the Treatment of Overactive Bladder

Detailed Study Description

Overactive Bladder with an average of 1 incontinency episode per day

Has urinary frequency and urgency with incontinence for at least 3 months

Clinical Study Identifier: TX137488

Find a site near you

Start Over

AdvanceMed Research

2 Princess Road, Suite J Lawrenceville, NJ USA
  Connect »